Literature DB >> 25291198

The physiological interferon response.

V Bocci1.   

Abstract

Some years ago Velio Bocci proposed, 1,2 against then current thinking, 3-6 that interferon (IFN) was produced continuously in health, in low 'physiological' amounts which increased occasionally when a viral disease induced an acute response. Since then, he argues here, data have accumulated which indicate that this 'physiological' IFN response may indeed be a reality.
Copyright © 1985. Published by Elsevier B.V.

Entities:  

Year:  1985        PMID： 25291198     DOI： 10.1016/0167-5699(85)90159-8

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


  7 in total

1.  Effect of molecular weight on the lymphatic absorption of water-soluble compounds following subcutaneous administration.

Authors:  A Supersaxo; W R Hein; H Steffen
Journal:  Pharm Res       Date:  1990-02       Impact factor: 4.200

Review 2.  Host-Intrinsic Interferon Status in Infection and Immunity.

Authors:  Beiyun C Liu; Joseph Sarhan; Alexander Poltorak
Journal:  Trends Mol Med       Date:  2018-07-07       Impact factor: 11.951

3.  Recombinant human interferon alpha-2a: delivery to lymphoid tissue by selected modes of application.

Authors:  A Supersaxo; W Hein; H Gallati; H Steffen
Journal:  Pharm Res       Date:  1988-08       Impact factor: 4.200

4.  The lymphatic route. 1) Albumin and hyaluronidase modify the normal distribution of interferon in lymph and plasma.

Authors:  V Bocci; M Muscettola; G Grasso; Z Magyar; A Naldini; G Szabo
Journal:  Experientia       Date:  1986-04-15

5.  No inhibition of interferon gamma release in human lymphocytes by Ciamexone.

Authors:  J Baier; H A Neumann; O Ricken
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

6.  Local interferon therapy for lip carcinoma.

Authors:  D Ikić; I Padovan; N Pipić; N Daković; Z Kusić
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

7.  Constitutive Interferon Maintains GBP Expression Required for Release of Bacterial Components Upstream of Pyroptosis and Anti-DNA Responses.

Authors:  Beiyun C Liu; Joseph Sarhan; Alexander Panda; Hayley I Muendlein; Vladimir Ilyukha; Jörn Coers; Masahiro Yamamoto; Ralph R Isberg; Alexander Poltorak
Journal:  Cell Rep       Date:  2018-07-03       Impact factor: 9.423
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.